Life Sciences
Top stories summarized by our editors
12/15/2017

A round of Series B funding brought in $63 million for Relay Therapeutics. The company plans to launch a clinical testing of an oncology program in 2019.

Full Story:
BioCentury
More Summaries:
Relay Therapeutics
12/15/2017

Scientists from the US and Germany have developed a way to turn Greek yogurt waste into biofuel. Utilizing bacteria, leftover acids and sugars from the yogurt are turned into molecules that can be used in the production of biofuels.

Full Story:
Biofuels Digest
12/15/2017

The Ugandan government and agriculture experts are promoting a fast-maturing, high-yield variety biotech super bean, called NABE15, that can resist drought and possibly give hope to hunger-prone areas of Africa.

Full Story:
The Hindu (India)
12/15/2017

GCI Health named Kath Kerry and Rikki Jones as co-managing directors of its London offices. Jones has been with GCI since 2014 and Kerry, a newer hire, has been serving as acting co-MD for the past year.

More Summaries:
GCI Health, GCI
12/15/2017

AstraZeneca has enlisted Bob Harper, an author, personal trainer and a coach on the television show "The Biggest Loser," to be the face of its "Survivors Have Heart" initiative. The online campaign asks people who've survived a heart attack in the past three years to tell their stories in 500 words or less, with five story writers to be chosen for a trip to New York to meet Harper.

Full Story:
FiercePharma
More Summaries:
AstraZeneca, Bob Harper
12/15/2017

The tax reform bill working its way through Congress is shaping up to be a net boon for the life sciences industry and its marketers, although there are still some hurdles to cross, writes John Kamp, executive director at the Coalition for Healthcare Communication. Recent drafts of the bill did not include a reduction in the amount marketers can deduct for client expenses, but as lobbyists continue to push for popular proposals such as state and local tax deductions, the $168 million in revenue from the marketing tax provision remains a target, he writes.

12/15/2017

Wright Medical agreed to pay $46.9 million in cash, $15.6 million of shares and $26.3 million in potential earn-out or milestone payments for Imascap, developer of the Glenosys shoulder replacement surgery preoperative planning software used in Wright's Blueprint 3D planning software. The Glenosys technology uses CT image data to enable simulation of a shoulder prosthesis' position and allows for 3D visualization of the shoulder.

Full Story:
MassDevice (Boston)
More Summaries:
Wright Medical, Wright
12/15/2017

A round of Series E financing involving Koch Disruptive Technologies, Elbit Imaging, GE Healthcare and other investors has pulled in $150 million for commercial-stage medical device company Insightec, which offers MRI-guided focused ultrasound for surgery. Proceeds from the pre-IPO round will be used for further commercialization of the company's approved indications and continued research in Alzheimer's disease, Parkinson's disease, brain tumors and other areas.

Full Story:
FinSMEs
12/15/2017

A venture loan facility worth $15 million from specialty finance firm Horizon Technology Finance was closed by Aerin Medical, which makes a noninvasive treatment platform for improving nasal breathing disorder symptoms. The money will be used as general working capital.

Full Story:
FinSMEs
12/15/2017

A round of Series A financing brought in $5.5 million for San Francisco-based medtech company Bay Labs, which applies deep learning and artificial intelligence to cardiovascular imaging. The proceeds will be used for acceleration of technological development, continued clinical validation and US marketing of the company's products.

Full Story:
FinSMEs